Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Hyperglycemia-induced Tau cleavage in vitro and in vivo: a possible link between
diabetes and Alzheimer's disease.
Authors
Kim B, Backus C, Oh S, Feldman EL
Submitted By
Eva Feldman on 7/10/2013
Status
Published
Journal
Journal of Alzheimer's disease : JAD
Year
2013
Date Published
12/1/2012
Volume : Pages
34 : 727 - 739
PubMed Reference
23254634
Abstract
Multiple lines of evidence link the incidence of diabetes to the development of
Alzheimer's disease (AD). Patients with diabetes have a 50 to 75% increased risk
of developing AD. In parallel, AD patients have a higher than normal tendency to
develop type 2 diabetes or impaired fasting glucose. Tau is the major component
of neurofibrillary tangles, one of the hallmarks of AD pathology. The current
study examined the effect of hyperglycemia on tau modification. Glucose
treatment of rat embryonic cortical neurons results in concentration-dependent
apoptosis and caspase-3 activation. These changes are well correlated with
glucose time- and concentration-dependent tau cleavage. Aß treatment induces tau
cleavage and when added together with glucose, there is an additive effect on
caspase activation, apoptosis, and tau cleavage. Tau cleavage is partially
blocked by the caspase inhibitor, ZVAD. Cleaved tau displays a punctate staining
along the neurites and colocalizes with cleaved caspase-3 in the cytoplasm. Both
type 1 and type 2 diabetic mice display increased tau phosphorylation in the
brain. In agreement with the effects of glucose on tau modifications in vitro,
there is increased tau cleavage in the brains of ob/ob mice; however, tau
cleavage is not observed in type 1 diabetic mouse brains. Our study demonstrates
that hyperglycemia is one of major factors that induce tau modification in both
in vitro and in vivo models of diabetes. We speculate that tau cleavage in
diabetic conditions (especially in type 2 diabetes) may be a key link for the
increased incidence of AD in diabetic patients.
Investigators with authorship
Name
Institution
Eva Feldman
University of Michigan
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!